89bio, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 13 rows in 2019. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2019-11-08: Reporting owner Hayden Michael R; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2019-11-08: Reporting owner Hayden Michael R; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2019-11-08: Reporting owner Hayden Michael R; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2019-11-08: Reporting owner Le-Nguyen Quoc; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2019-11-08 holding as of filing | Hayden Michael R Director | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $1.93 exercise price | 2019-11-08 | ||
| 2019-11-08 holding as of filing | Hayden Michael R Director | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $1.93 exercise price | 2019-11-08 | ||
| 2019-11-08 holding as of filing | Hayden Michael R Director | 3 | Stock Option (Right to Buy) Derivative · Direct · (m) | Holding | $3.11 exercise price | 2019-11-08 | ||
| 2019-11-08 holding as of filing | Le-Nguyen Quoc Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.11 exercise price | 2019-11-08 | ||
| 2019-11-08 holding as of filing | Le-Nguyen Quoc Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.11 exercise price | 2019-11-08 | ||
| 2019-11-08 holding as of filing | Mansbach Harry H Officer (Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.93 exercise price | 2019-11-08 | ||
| 2019-11-08 holding as of filing | Mansbach Harry H Officer (Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.11 exercise price | 2019-11-08 | ||
| 2019-11-08 holding as of filing | Waisbourd Ram Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.93 exercise price | 2019-11-08 | ||
| 2019-11-08 holding as of filing | Waisbourd Ram Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.93 exercise price | 2019-11-08 | ||
| 2019-11-08 holding as of filing | Waisbourd Ram Officer (See Remarks) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.11 exercise price | 2019-11-08 | ||
| 2019-11-08 holding as of filing | Martins Ryan Officer (Chief Financial Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.11 exercise price | 2019-11-08 | ||
| 2019-11-08 holding as of filing | PALEKAR ROHAN Director, Officer (Chief Executive Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.93 exercise price | 2019-11-08 | ||
| 2019-11-08 holding as of filing | PALEKAR ROHAN Director, Officer (Chief Executive Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $3.11 exercise price | 2019-11-08 |